GlassScriptPhysician profile
Sophia Drosinos
NPI 1023014933
$4,290.94
in general payments reported to CMS, 2019-2025
22 companies · $746 in 2025
The $746 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $542 · 2020: $182 · 2021: $856 · 2022: $812 · 2023: $602 · 2024: $551 · 2025: $746.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,862 · Education: $36.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,861.78 |
| Education | $36.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,334.27 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Astellas Pharma US INC | $606.36 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $457.59 | 2022-2025 | |
| Exeltis, USA INC. | $356.73 | 2020-2025 | Slynd |
| Sumitomo Pharma America, INC. | $247.08 | 2023-2024 | Myfembree |
| Myovant Sciences INC. | $212.51 | 2022 | |
| Biogen, INC. | $171.44 | 2025 | Zurzuvae |
| Avion Pharmaceuticals | $150.59 | 2021-2023 | Divigel |
| Therapeuticsmd, INC. | $124.86 | 2019-2021 | |
| Millicent US INC | $85.79 | 2019-2020 | |
| Shield Therapeutics INC | $83.41 | 2023-2024 | Accrufer |
| Pfizer INC. | $73.86 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $66.44 | 2021-2022 | |
| Evofem Biosciences, INC. | $66.08 | 2022-2024 | Phexxi |
| Vertical Pharmaceuticals, LLC | $62.84 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $48.59 | 2019 | |
| Coopersurgical, INC. | $42.03 | 2021 | |
| Duchesnay USA Incorporated | $24.93 | 2019 | |
| Aspira Women'S Health INC | $22.94 | 2019 | |
| Mission Pharmacal Company | $20.15 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.60 | 2020 | |
| Bausch Health US, LLC | $14.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sophia Drosinos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.